Y020-4358 Screening compound: 1-[5-(2H-1,3-benzodioxol-5-yl)-4-oxo-3H,4H-pyrido[2,3-d]pyrimidin-2-yl]piperidine-4-carboxamide

Y020-4358 Screening compound: 1-[5-(2H-1,3-benzodioxol-5-yl)-4-oxo-3H,4H-pyrido[2,3-d]pyrimidin-2-yl]piperidine-4-carboxamide
Y020-4358 Screening compound: 1-[5-(2H-1,3-benzodioxol-5-yl)-4-oxo-3H,4H-pyrido[2,3-d]pyrimidin-2-yl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-4358
1-[5-(2H-1,3-benzodioxol-5-yl)-4-oxo-3H,4H-pyrido[2,3-d]pyrimidin-2-yl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-4358

Molecular Formula

C20H19N5O4 (C20 H19 N5 O4)

Compound Name

1-[5-(2H-1,3-benzodioxol-5-yl)-4-oxo-3H,4H-pyrido[2,3-d]pyrimidin-2-yl]piperidine-4-carboxamide

IUPAC name

1-[5-(2H-13-benzodioxol-5-yl)-4-oxo-3H4H-pyrido[23-d]pyrimidin-2-yl]piperidine-4-carboxamide

SMILES

NC(C(CC1)CCN1C(N1)=Nc(nccc2-c(cc3)cc4c3OCO4)c2C1=O)=O

InChI

InChI=1S/C20H19N5O4/c21-17(26)11-4-7-25(8-5-11)20-23-18-16(19(27)24-20)13(3-6-22-18)12-1-2-14-15(9-12)29-10-28-14/h1-3,6,9,11H,4-5,7-8,10H2,(H2,21,26)(H,22,23,24,27)

InChI Key

XAPTXUAVIHUNFB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD18070532

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

393.4

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.585

Distribution Coefficient, logD

1.580

Water Solubility, LogSw

-2.34

Polar Surface Area

98.483

Acid Dissociation Constant (pKa)

9.43

Base Dissociation Constant (pKb)

4.81

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

Y020-4358 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with Y020-4358 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-4358?
Check Price and Availability of Y020-4358, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-4358 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-4358
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-4358
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-4358 available by request